Since clinical trials of anti-inflammatory therapies, such as anti-TNF-α approaches, have to date failed to show benefit in HF patients [6], a better definition of the role of inflammation in HF and new therapeutic targets are urgently required from basic research. The gene discussed is TNF; the disease is hydrops fetalis.